Early, Short Course Of Hormonal Therapy May Allow Patients To Live Longer
High-Dose Chemo, Stem Cell Transplant No Benefit For Node+ Breast Cancer
Xeloda, Taxotere, Herceptin Combination May Benefit Invasive Breast Cancer
Longterm Followup Finds Taxotere Improves Survival
Drug Combination Tested For B.C. Brain Metastases
Sunitinib May Be Associated With Cardiac Toxicity
BRCA Carriers Live Longer Than Those With Normal Gene
Rev/Vel/Dex Response Rate High In Phase I/II Study
FDA Approves Genetic Test For Breast Cancer Patients
NCI Cooperative Group, Cancer Center Trials Listed
Trending Stories
- Class action complaint alleging GRAIL insider fraud resubmitted after dismissal
- Cancer centers adapt to life without site visits as NIH changes CCSG review
- How GLP-1RA drugs are reshaping patient physiology and the future of oncology
- Friends publishes three white papers ahead of annual meeting
Topics: Clinical trials on rare cancers, combination drug trials, multi-regional studies - Jonathan Licht named president, chief scientific officer at Van Andel Institute
- Revolution Medicines’ pancreatic cancer drug received a new priority voucher from FDA









